Pharmaceutical Business Review
Anonymous User | Login

WHO Grants Prequalification To GSK’ Cervarix

Published: 09-Jul-2009

GSK is participating in a number of HPV vaccination demonstration projects to introduce the vaccine

The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline' (GSK) cervical cancer vaccine.

GSK filed Cervarix for WHO prequalification in September 2007, less than one week after the vaccine was approved by the European Medicines Agency. Registration with a major regulatory agency is a required step for any WHO prequalification filing.

Jean Stephenne, President of GSK Biologicals, said: “Cervarix can save millions of women’s lives throughout the world, but only if it reaches those who need it most. That is why GSK rapidly applied for WHO prequalification of Cervarix. That is why we’re eager to work with our long-term partner GAVI as well as other private NGOs or governments of developing countries to identify financing mechanisms for the vaccine. And that is why we’re exploring a variety of distribution partnerships to ensure Cervarix will protect women and girls around the globe.”

To overcome the challenges of introducing a cervical cancer vaccine in developing countries, GSK is participating in a number of HPV vaccination demonstration projects, including those led by PATH in Uganda and India. It has donated more than 100,000 doses of Cervarix to these programs. These collaborations would help build and leverage developing countries’ experience with the implementation of HPV vaccination programs, said the company.

Christopher Elias, President and CEO of PATH, said: “Through our joint demonstration project, we have found that we can achieve high HPV vaccination coverage through proper sensitisation, the strengthening of healthcare systems and the mobilisation of local communities. With today’s WHO decision, the public and private sectors take another significant step forward in accelerating access to HPV vaccines in GAVI countries. We look forward to continuing to partner with GSK on this public health priority.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

GRACO

World Leader in Fluid Handling Systems and Components ...

Burkert Fluid Control Systems

Fluid and Gas Control Systems ...

eResearch Technology

Provider of Technology and Services ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

PFC Pharma Focus

Planning And Conducting Clinical Phase I To IV Studies ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the desig ...

Schering-Plough Corporation

Schering-Plough Corporation (Schering-Plough) is a pharmaceutical company focused on di ...

Amgen Inc.

Amgen Inc. (Amgen) is a biotechnology company that is focused on the discovery, develo ...

Abbott Laboratories

Abbott Laboratories (Abbott) is a global health care company. It is principally engaged ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials

ERT, a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, announced today the launch of a unique online web interface – My Study Portal.

ERT Officials Ring the NASDAQ Closing Bell

ERT (NASDAQ: ERES), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the biopharmaceutical, medical device and related industries, closed the stock market on 18 June by ringing the famous NASDAQ bell.

ERT Relocates Customer Care Team to Provide Stronger Client Support

ERT a leading provider of centralized ECG, ePRO, eClinical technology and other services to the biopharmaceutical, medical device and related industries, is to move its dedicated customer care team to its new state-of-the-art headquarters and logistics operations in Philadelphia.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address